{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:24:00Z","timestamp":1792873440128,"version":"4.5.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Background<\/jats:title>\n Mesothelin (MSLN) is a cell surface glycoprotein that is often over-expressed in various malignancies of humans and has been suggested as a potential therapeutic and diagnostic target. However, its expression profile, clinical implications and drug-targeting potential are not fully understood and needs to be investigated across various cancer types.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n The goal of this study was to systematically characterize the MSLN expression pattern, its prognostic value and functionality in different types of cancers, particularly in pancreatic adenocarcinoma (PAAD), as well as to identify viable therapeutic target opportunities.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Transcriptomic and clinical datasets from TCGA and GEO were used to evaluate the expression of the MSLN gene, diagnostic value, and its prognostic significance. To study the genomic alterations and functional pathways of MSLN, mutation, GO, and KEGG analyses were used. Drug sensitivity correlations were performed with GDSC and CTRP datasets. Structure-based drug discovery involved molecular docking (AutoDock Vina and Maestro Glide), 100 ns molecular dynamics simulations, and MMPBSA binding free energy analysis, followed by drug-likeness and toxicity assessment using SwissADME and ProTox-III.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n MSLN was found to be over expressed in several cancers, including PAAD, ovarian and mesothelioma, and this was confirmed in the independent GEO datasets. The analysis of ROC curves showed high accuracy for PAAD and stomach adenocarcinoma and moderate to low accuracy for the other cancers. Both survival and Cox regression analyses showed that MSLN was a cancer-type-specific prognostic factor. Analysis of mutations showed low frequencies of genetic changes, suggesting that the mechanism of dysregulation may be transcriptional or epigenetic. Enrichment analysis highlighted immune-related and tumor-microenvironment signaling pathways associated with MSLN. Drug sensitivity analysis suggested association of MSLN expression with response to targeted and selected chemotherapeutic drugs. Molecular docking revealed Withaferin A as the most potent protein binding compound with MSLN with stable protein-ligand interaction as evidenced by molecular dynamics simulations and binding energy analysis.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n MSLN is a diagnosis and prognosis biomarker that is context dependent and has application in selected cancers, especially pancreatic adenocarcinoma. While Withaferin A shows promising in silico binding and stability against MSLN, predicted toxicity and pharmacokinetic limitations suggest the need for further optimization and experimental validation before therapeutic application.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0354334","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T17:36:32Z","timestamp":1787247392000},"page":"e0354334","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pan-cancer profiles of mesothelin (MSLN) unveil diagnostic potential and therapeutic targetability of pancreatic adenocarcinoma"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8248-7869","authenticated-orcid":true,"given":"Md Ramjan","family":"Sheikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baishakhi","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridika Haque","family":"Shafin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amreeta","family":"Apu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasnia Hossain","family":"Sara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarin","family":"Tasnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipankar","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Nandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"3","key":"pone.0354334.ref001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA A Cancer J Clinicians"},{"issue":"10","key":"pone.0354334.ref002","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3390\/cancers17101607","article-title":"Unraveling the Burden of Pancreatic Cancer in the 21st Century: Trends in Incidence, Mortality, Survival, and Key Contributing Factors","volume":"17","author":"J Zottl","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"2","key":"pone.0354334.ref003","first-page":"130","article-title":"Catching pancreatic cancer early: Are we there yet?","volume":"6","author":"ARA Rasheed","year":"2025","journal-title":"J Natl Cancer Cent"},{"issue":"12","key":"pone.0354334.ref004","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-03-0801","article-title":"Mesothelin: a new target for immunotherapy","volume":"10","author":"R Hassan","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"2","key":"pone.0354334.ref005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1158\/2159-8290.CD-15-0583","article-title":"Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors","volume":"6","author":"A Morello","year":"2016","journal-title":"Cancer Discov"},{"issue":"8","key":"pone.0354334.ref006","article-title":"MSLN induced EMT, cancer stem cell traits and chemotherapy resistance of pancreatic cancer cells","volume":"10","author":"J Hu","year":"2024","journal-title":"Heliyon"},{"issue":"10","key":"pone.0354334.ref007","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"A Rump","year":"2004","journal-title":"J Biol Chem"},{"issue":"10","key":"pone.0354334.ref008","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1158\/1078-0432.CCR-04-2304","article-title":"Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients","volume":"11","author":"M Ho","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"2","key":"pone.0354334.ref009","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2174\/1871520611313020014","article-title":"The role of mesothelin in tumor progression and targeted therapy","volume":"13","author":"Z Tang","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"issue":"8","key":"pone.0354334.ref010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd.2016.29","article-title":"Small molecules, big targets: drug discovery faces the protein-protein interaction challenge","volume":"15","author":"DE Scott","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"pone.0354334.ref011","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41592-018-0020-4","article-title":"A pan-cancer atlas","volume":"15","author":"T Nawy","year":"2018","journal-title":"Nat Methods"},{"issue":"2","key":"pone.0354334.ref012","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic Signaling Pathways in The Cancer Genome Atlas","volume":"173","author":"F Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"pone.0354334.ref013","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq1184","article-title":"NCBI GEO: archive for functional genomics data sets--10 years on","volume":"39","author":"T Barrett","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0354334.ref014","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"R Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"88","key":"pone.0354334.ref015","first-page":"2016","article-title":"Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia","volume":"55","author":"L Badea","year":"2008","journal-title":"Hepato-Gastroenterol"},{"issue":"13","key":"pone.0354334.ref016","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1158\/0008-5472.CAN-15-2841","article-title":"A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2","volume":"76","author":"S Yang","year":"2016","journal-title":"Cancer Res"},{"key":"pone.0354334.ref017","unstructured":"Team RC. R A language and environment for statistical computing, R Foundation for Statistical. Computing. 2020."},{"issue":"6","key":"pone.0354334.ref018","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2307\/3001968","article-title":"Individual Comparisons by Ranking Methods","volume":"1","author":"F Wilcoxon","year":"1945","journal-title":"Biom Bull"},{"issue":"282","key":"pone.0354334.ref019","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"EL Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"pone.0354334.ref020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression Models and Life-Tables","volume":"34","author":"DR Cox","year":"1972","journal-title":"J R Stat Soc B Stat Methodol"},{"issue":"11","key":"pone.0354334.ref021","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.21037\/jtd.2019.11.04","article-title":"The prognostic value of tumor mutation burden in EGFR-mutant advanced lung adenocarcinoma, an analysis based on cBioPortal data base","volume":"11","author":"X-D Jiao","year":"2019","journal-title":"J Thorac Dis"},{"issue":"11","key":"pone.0354334.ref022","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1007\/s12033-023-00704-3","article-title":"Prospective Identification of Prognostic Hot-Spot Mutant Gene Signatures for Leukemia: A Computational Study Based on Integrative Analysis of TCGA and cBioPortal Data","volume":"65","author":"M Zhang","year":"2023","journal-title":"Mol Biotechnol"},{"key":"pone.0354334.ref023","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/978-981-96-2911-4_6","article-title":"Construction and application of protein-protein interaction knowledge graph.","volume-title":"Artificial intelligence and robotics","author":"J Xiong","year":"2025"},{"issue":"1","key":"pone.0354334.ref024","article-title":"GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels","volume":"24","author":"C-J Liu","year":"2023","journal-title":"Brief Bioinform"},{"issue":"4","key":"pone.0354334.ref025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/14712598.2021.1843628","article-title":"Mesothelin-targeted CAR-T cell therapy for solid tumors","volume":"21","author":"A Klampatsa","year":"2021","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"pone.0354334.ref026","doi-asserted-by":"crossref","first-page":"2603105","DOI":"10.1080\/15384047.2025.2603105","article-title":"Novel perspectives on MSLN-targeted cancer therapy: from molecular mechanisms to clinical translation","volume":"26","author":"Z Wu","year":"2025","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"pone.0354334.ref027","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"O Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"13","key":"pone.0354334.ref028","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"EF Pettersen","year":"2004","journal-title":"J Comput Chem"},{"issue":"1","key":"pone.0354334.ref029","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s44371-026-00710-9","article-title":"In silico investigation of fenugreek-derived coumarin and its potential impact on human health","volume":"3","author":"MR Sheikh","year":"2026","journal-title":"Discov Chem"},{"issue":"12","key":"pone.0354334.ref030","first-page":"3862","article-title":"Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)","volume":"7","author":"P Argani","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"7549","key":"pone.0354334.ref031","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"DG Altman","year":"2006","journal-title":"BMJ"},{"issue":"1","key":"pone.0354334.ref032","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/biom15010071","article-title":"Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment","volume":"15","author":"K Liu","year":"2025","journal-title":"Biomolecules"},{"issue":"6","key":"pone.0354334.ref033","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3390\/cancers14061550","article-title":"Mesothelin: An Immunotherapeutic Target beyond Solid Tumors","volume":"14","author":"JR Faust","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"9","key":"pone.0354334.ref034","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nsb0902-646","article-title":"Molecular dynamics simulations of biomolecules","volume":"9","author":"M Karplus","year":"2002","journal-title":"Nat Struct Biol"},{"key":"pone.0354334.ref035","doi-asserted-by":"crossref","DOI":"10.1201\/9781032675961-8","article-title":"Steroidal lactones of ashwagandha: influence of geographical variations and molecular insights","volume-title":"Ashwagandha","author":"M Muley","year":"2025"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T17:36:40Z","timestamp":1787247400000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354334"}},"subtitle":[],"editor":[{"given":"Yusuf Oloruntoyin","family":"Ayipo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0354334","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}